No, the glycaemic target in the critically ill should not be ≤6.1 mmol/l

Diabetologia

Volumn 51, Issue 6, 2008, Pages 916-920

  Miles, J M ^a   McMahon, M M ^a   Isley, W L ^a  

^a MAYO CLINIC   (United States)

Author keywords

Hyperglycaemia; Intensive care; NEFA; Parenteral nutrition; Triacylglycerol

Indexed keywords

GLUCOSE; INSULIN;

CRITICALLY ILL PATIENT; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; INTENSIVE CARE UNIT; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; OVERNUTRITION; PARENTERAL NUTRITION; PRIORITY JOURNAL; REVIEW;

BLOOD GLUCOSE; CRITICAL ILLNESS; ENERGY METABOLISM; FEMALE; HUMANS; MALE; REFERENCE VALUES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 43049129962     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-007-0888-5     Document Type: Review

References (29)

1. Van den Berghe G (2007) Insulin therapy in the intensive care unit should be targeted to maintain blood glucose between 4.4 mmol/l and 6.1 mmol/l. Diabetologia DOI 10.1007/s00125-007-0878-7
2. Anonymous (2004) ACE position statement. Endocr Pract 10:5-9
3. Van den Berghe G, Wouters P, Weekers F et al (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359-1367
4. Malmberg K (1997) Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ 314:1512-1515
5. Furnary AP, Gao G, Grunkemeier GL et al (2003) Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 125:1007-1021
6. Krinsley JS (2004) Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc 79:992-1000
7. Van den Berghe G, Wilmer A, Hermans G et al (2006) Intensive insulin therapy in the medical ICU. N Engl J Med 354:449-461
8. Klein CJ, Stanek GS, Wiles CE 3rd (1998) Overfeeding macronutrients to critically ill adults: metabolic complications. J Am Diet Assoc 98:795-806
9. Anonymous (1991) Perioperative total parenteral nutrition in surgical patients. The Veterans Affairs Total Parenteral Nutrition Cooperative Study Group. N Engl J Med 325:525-532
10. Klein S, Kinney J, Jeejeebhoy K, Alpers D et al (1997) Nutrition support in clinical practice: review of published data and recommendations for future research directions. Summary of a conference sponsored by the National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition. Am J Clin Nutr 66:683-706
11. Braunschweig CL, Levy P, Sheean PM, Wang X (2001) Enteral compared with parenteral nutrition: a meta-analysis. Am J Clin Nutr 74:534-542
12. Sax HC, Warner BW, Talamini MA et al (1987) Early total parenteral nutrition in acute pancreatitis: lack of beneficial effects. Am J Surg 153:117-124
13. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE (2002) Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 87:978-982
14. McMahon MM, Bistrian BR (1995) Host defenses and susceptibility to infection in patients with diabetes mellitus. Infect Dis Clin North Am 9:1-9
15. Bagdade JD, Root RK, Bulger RJ (1974) Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes 23:9-15
16. Mesotten D, Swinnen JV, Vanderhoydonc F, Wouters PJ, Van den Berghe G (2004) Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metab 89:219-226
17. Albrink MJ, Krauss RM, Lindgrem FT, von der Groeben J, Pan S, Wood PD (1980) Intercorrelations among plasma high density lipoprotein, obesity and triglycerides in a normal population. Lipids 15:668-676
18. Battistella FD, Widergren JT, Anderson JT, Siepler JK, Weber JC, MacColl K (1997) A prospective, randomized trial of intravenous fat emulsion administration in trauma victims requiring total parenteral nutrition. J Trauma 43:52-58
19. Miles JM (1991) Intravenous fat emulsions in nutritional support. Curr Opin Gastroenterol 7:306-311
20. Freeman J, Goldmann DA, Smith NE, Sidebottom DG, Epstein MF, Platt R (1990) Association of intravenous lipid emulsion and coagulase-negative staphylococcal bacteremia in neonatal intensive care units. N Engl J Med 325:301-308
21. Seidner DL, Mascioli EA, Istfan NW et al (1989) Effects of long-chain triglyceride emulsions on reticuloendothelial system function in humans. J Parenter Enteral Nutr 13:614-619
22. Jensen MD, Caruso M, Heiling VJ, Miles JM (1989) Insulin regulation of lipolysis in nondiabetic and IDDM subjects. Diabetes 38:1595-1601
23. Korvald C, Elvenes OP, Myrmel T (2000) Myocardial substrate metabolism influences left ventricular energetics in vivo. Am J Physiol 278:H1345-H1351
24. Steinberg HO, Tarshoby M, Monestel R et al (1997) Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest 100:1230-1239
25. Stojiljkovic MP, Zhang D, Lopes HF, Lee CG, Goodfriend TL, Egan BM (2001) Hemodynamic effects of lipids in humans. Am J Physiol 280:R1674-R1679
26. Van den Berghe G, Wouters PJ, Bouillon R et al (2003) Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose vs glycemic control. Crit Care Med 31:359-366
27. Miles JM (2006) Energy expenditure in hospitalized patients: implications for nutritional support. Mayo Clin Proc 81:809-816
28. Cerra FB, Benitez MR, Blackburn GL et al (1997) Applied nutrition in ICU patients. A consensus statement of the American College of Chest Physicians. Chest 111:769-778
29. Cryer PE (2006) Hypoglycaemia: the limiting factor in the glycaemic management of the critically ill? Diabetologia 49:1722-1725